USANA Health Sciences was founded in 1992 by Dr. Myron Wentz, a microbiologist and immunologist, and is headquartered in Salt Lake City, Utah. The China division, operating from Beijing, represents one of USANA s largest and most strategically important international markets. USANA entered the Chinese market through a direct-selling license granted by the Chinese Ministry of Commerce and has built a substantial presence with dedicated manufacturing, distribution, and support facilities serving the mainland Chinese market. USANA China operates under the BabyCare brand and direct-selling regulations specific to China s legal framework.
USANA is known for its science-based nutritional supplements, which are developed by an in-house team of scientists in the company s own research laboratories. Core product lines include the CellSentials (daily nutritional supplements), Proflavanol C (antioxidant supplement), BiOmega (fish oil supplement), and the MySmart protein shake system. In China, USANA also markets products under the BabyCare brand, focusing on skincare, personal care, and household products that comply with Chinese direct-selling product regulations. USANA operates an FDA-registered manufacturing facility in Salt Lake City and a dedicated facility in Beijing for the Chinese market.
USANA has invested heavily in scientific research and quality control, earning recognition from third-party testing organizations such as NSF International and ConsumerLab. The company s products are manufactured in accordance with pharmaceutical-grade Good Manufacturing Practices (GMP), and the company publishes quality testing results for its products. Dr. Wentz founded USANA based on his research in cellular nutrition, and the company continues to fund research into the relationship between nutritional supplementation and cellular health. USANA has published peer-reviewed scientific studies and sponsors clinical research at universities.
China represents a unique operating environment for direct-selling companies due to strict government regulations. Companies must obtain a direct-selling license from the Ministry of Commerce and comply with regulations that prohibit traditional multi-level compensation structures. USANA China has adapted its business model to comply with these regulations, operating through a combination of direct-selling representatives, retail outlets (experience centers), and e-commerce channels. The company has invested in local manufacturing to comply with Chinese product registration and labeling requirements.
USANA Health Sciences operates in approximately 24 markets worldwide, including the United States, Canada, Australia, New Zealand, multiple Asian markets, and Europe. The company is publicly traded on the New York Stock Exchange and has consistently been recognized on the Direct Selling News Global 100 list. USANA s annual revenue has exceeded one billion dollars, with the Asia-Pacific region (including China) representing a significant portion of total sales. The company employs thousands of corporate staff and supports hundreds of thousands of independent distributors, known as Associates, globally.
USANA has established itself as a trusted supplement provider for professional and Olympic athletes through partnerships and endorsements. The company s products are third-party tested and certified free of banned substances, which has led to endorsement deals with numerous Olympic athletes and professional sports teams. USANA has served as the official health supplement supplier of several national Olympic teams, reinforcing its positioning as a premium, science-backed supplement brand.
USANA employs a binary compensation structure globally, though the China operations are modified to comply with local direct-selling regulations that restrict multi-level compensation.
